chr5-111121006-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The ENST00000513710.4(WDR36):c.2013A>T(p.Val671=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.308 in 1,610,660 control chromosomes in the GnomAD database, including 80,231 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.26 ( 6073 hom., cov: 32)
Exomes 𝑓: 0.31 ( 74158 hom. )
Consequence
WDR36
ENST00000513710.4 synonymous
ENST00000513710.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.955
Genes affected
WDR36 (HGNC:30696): (WD repeat domain 36) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. Mutations in this gene have been associated with adult-onset primary open-angle glaucoma (POAG). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 5-111121006-A-T is Benign according to our data. Variant chr5-111121006-A-T is described in ClinVar as [Benign]. Clinvar id is 262465.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-111121006-A-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.955 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.379 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR36 | NM_139281.3 | c.2013A>T | p.Val671= | synonymous_variant | 19/23 | ENST00000513710.4 | NP_644810.2 | |
WDR36 | XM_047416729.1 | c.2013A>T | p.Val671= | synonymous_variant | 19/21 | XP_047272685.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR36 | ENST00000513710.4 | c.2013A>T | p.Val671= | synonymous_variant | 19/23 | 1 | NM_139281.3 | ENSP00000424628 | P1 |
Frequencies
GnomAD3 genomes AF: 0.261 AC: 39686AN: 151916Hom.: 6077 Cov.: 32
GnomAD3 genomes
AF:
AC:
39686
AN:
151916
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.329 AC: 81934AN: 249122Hom.: 14551 AF XY: 0.334 AC XY: 45032AN XY: 134900
GnomAD3 exomes
AF:
AC:
81934
AN:
249122
Hom.:
AF XY:
AC XY:
45032
AN XY:
134900
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.313 AC: 456833AN: 1458626Hom.: 74158 Cov.: 34 AF XY: 0.317 AC XY: 230081AN XY: 725656
GnomAD4 exome
AF:
AC:
456833
AN:
1458626
Hom.:
Cov.:
34
AF XY:
AC XY:
230081
AN XY:
725656
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.261 AC: 39669AN: 152034Hom.: 6073 Cov.: 32 AF XY: 0.268 AC XY: 19927AN XY: 74314
GnomAD4 genome
AF:
AC:
39669
AN:
152034
Hom.:
Cov.:
32
AF XY:
AC XY:
19927
AN XY:
74314
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1029
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 10, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Glaucoma 1, open angle, G Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at